Delivery Order SPE2DB24D2105-SPE2DB24FAPHM
- Not listed
- This federal contract award, valued at $7,569.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
- This federal contract award, valued at $6,269.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. It is a Firm Fixed Price Delivery Order contract with a completion date of June 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $5,566.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $3,953.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $14,171.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a Firm Fixed Price Delivery Order contract with a performance period extending to May 15, 2025. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $8,038.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. The contract is not a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $1,758.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm fixed-price, delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $17,740.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award, valued at $5,962.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract is a firm fixed-price Delivery Order with a completion date of January 24, 2025 and is not designated as a set-aside. AmerisourceBergen, a for-profit organization, maintains an Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,192.75 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FAPHMDelivery Order
This federal contract award, valued at $32,589.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of May 29, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.6k | 5/28/24 |